文献速递心力衰竭与心肌病

内源性逆转录病毒异常复活诱发心肌炎和心力衰竭

An Aberrant Resurgence of Endogenous Retroviruses Prompts Myocarditis and Heart Failure.
PubMed 文献 · Circulation · 2025-08-18

该研究探讨内源性逆转录病毒(ERV)在心力衰竭(HF)中的作用,通过跨物种HF模型发现I类ERV激活,TRIM28缺失导致表观遗传监视减弱,激活TLR7/9-NF-κB先天免疫通路,诱发心肌炎和急性HF,抑制该通路可改善心功能。

要点

  • ERV复活是HF的分子特征,由心肌细胞TRIM28缺失驱动。
  • ERV激活通过TLR7/9-NF-κB通路诱发心肌炎和HF。
  • 靶向TRIM28-ERV-TLR7/9-NF-κB通路可治疗心肌炎和HF。

核心结论

  • ERV复活是HF的特异性分子特征,由心肌细胞TRIM28缺失驱动。
  • ERV复活激活先天免疫TLR7/9-NF-κB通路,诱导心肌炎和HF。
  • 抑制ERV激活或ERV介导的免疫通路可保护心脏。

研究设计与样本

  • 建立总RNA测序分析流程评估人和小鼠HF模型中的ERV发生。
  • 构建两种心肌特异性小鼠品系:Myh6-MerCreMer与TRIM28f/f和SETDB1f/f杂交。
  • 使用AAV9过表达TRIM28抑制ERV激活。
  • 在心肌缺血/再灌注模型中测试ERV介导炎症通路的治疗潜力。

主要发现

  • ERVs(特别是I类ERVs)在多种跨物种HF模型中显著激活。
  • TRIM28缺失减弱H3K9me3和m6A的表观遗传监视,导致衰竭心脏中ERV激活。
  • ERV激活刺激TLR7/9和NF-κB抗病毒先天免疫通路,导致心肌炎和急性HF。
  • AAV9介导的TRIM28表达或小分子TLR7/9抑制剂改善缺血/再灌注模型的心功能并缓解HF。

临床怎么用

  • TRIM28-ERV-TLR7/9-NF-κB可作为心肌炎和HF治疗管理的靶点。
  • 抑制TLR7/9通路或增强TRIM28表达可能保护心脏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endogenous retroviruses (ERVs) occupy >8% of the human genome. Aberrant resurgence of ERVs has been implicated recently in several critical pathologies. However, the possible incidence and role of ERV resurgence in heart failure (HF), a leading cause of global morbidity and mortality, remain unexplored. METHODS: We established a total RNA sequencing analyzing pipeline to assess the ERV occurrence in human and murine HF models. We generated 2 myocardium-specific mouse lines by crossing Myh6-MerCreMer (Myosin heavy chain 6 promoter driving MerCreMer recombinase) with TRIM28f/f and SETDB1f/f mice to identify the molecular regulators of ERV resurgence and the downstream pathways in the heart. We evaluated ERV expression by total RNA sequencing, reverse transcription-quantitative polymerase chain reaction and RNA fluorescence in situ hybridization. We restrained ERV activation by overexpressing TRIM28 (tripartite motif-containing 28) using adeno-associated virus serotype 9. The therapeutic potential of the ERV-mediated inflammatory pathway was tested in a myocardial ischemia/reperfusion model. RESULTS: ERVs, particularly class I ERVs, were prominently activated in multiple cross-species models of HF. Depletion of TRIM28, an epigenetic repressor, attenuated the epigenetic surveillance of trimethylation at lysine 9 of histone H3 and N6-methyladenosine, leading to the activation of ERVs in the failing heart. This ERV activation stimulated the antiviral innate immune pathways of TLR7/9 (Toll-like receptor 7/9) and NF-κB and lead to myocarditis and acute HF. Furthermore, restraining ERV activation and ERV-mediated innate immune responses by either adeno-associated virus serotype 9-mediated TRIM28 expression or a small-molecule TLR7/9 inhibitor improved heart function and alleviated HF in an ischemia/reperfusion model. CONCLUSIONS: ERV resurgence is a specific molecular trait of HF, driven by TRIM28 depletion in cardiomyocytes. ERV resurgence activates the innate immune TLR7/9-NF-κB pathway and induces myocarditis and HF. Inception of ERVs and the ERV-mediated immune pathway confers cardiac protection. These results identify TRIM28-ERV-TLR7/9-NF-κB as a target for therapeutic management of myocarditis and HF.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Xiong, Zhang, Geng, et al. An Aberrant Resurgence of Endogenous Retroviruses Prompts Myocarditis and Heart Failure. Circulation. 2025. PMID: 40820798. doi:10.1161/CIRCULATIONAHA.125.074845

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。